Vadim Gladyshev is a professor of medicine at Harvard Medical School and Director of Redox Medicine at Brigham and Women's Hospital. He leads a broad program on aging, longevity and rejuvenation using computational and experimental approaches. Gladyshev is a member of the National Academy of Science, has won many awards for his work and has published more than 400 scientific articles. He serves on the LongeVC Advisory Board.
Gladyshev is known for his characterization of the human selenoproteome. He has studied the process of how organisms can acquire cellular damage from their food and the role selenium plays as a micro-nutrient with significant health benefits. In 2013, he won the National Institutes of Health Pioneer Award.
Gladyshev obtained his education at MSU. He completed his postdoctoral training under Dr. Thressa Stadtman of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and then with the Dolph L. Hatfield, National Cancer Institute (NCI).